Search

Search Results
Results 251 - 260 of 266 for light therapy
  • Kanjinti
    Drug - 11 Feb 2022
    Consumer Medicine Information (CMI) about Kanjinti (trastuzumab) intended for persons living in Australia.
  • Aratac
    Drug - 25 Jan 2022
    Consumer Medicine Information (CMI) about Aratac (amiodarone hydrochloride) intended for persons living in Australia.
  • Mylotarg
    Drug - 11 Jan 2022
    Consumer Medicine Information (CMI) about Mylotarg (Gemtuzumab ozogamicin) intended for persons living in Australia.
  • Mabcampath
    Drug - 10 Jan 2022
    Consumer Medicine Information (CMI) about Mabcampath intended for persons living in Australia.
  • DBL Magnesium Sulfate Concentrated Injection
    Drug - 7 Nov 2021
    Consumer Medicine Information (CMI) about DBL Magnesium Sulfate Concentrated Injection intended for persons living in Australia.
  • Panamax
    Drug - 3 Nov 2021
    Consumer Medicine Information (CMI) about Panamax intended for persons living in Australia.
  • Abilify Maintena Therapeutic Kit
    Drug - 1 Jul 2021
    Consumer Medicine Information (CMI) about Abilify Maintena Therapeutic Kit intended for persons living in Australia.
  • Actonel
    Drug - 29 Apr 2021
    Consumer Medicine Information (CMI) about Actonel intended for persons living in Australia.
  • Loette (New Formulation)
    Drug - 16 Nov 2020
    Consumer Medicine Information (CMI) about Loette (New Formulation) (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback